Simple gene test could spot rare gut condition

NCT ID NCT07448753

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study is testing whether checking two specific genes (ACTG2 and FLNA) in blood or saliva can help diagnose a rare condition called chronic intestinal pseudo-obstruction (CIPO), where the gut acts like it is blocked but no physical blockage exists. Researchers will enroll 20 adults with CIPO who also have weak or absent muscle contractions in the esophagus. The goal is to see how often these gene changes occur in this specific group, which could lead to a simpler, less invasive diagnostic test.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this could lead to a simple blood or saliva test to diagnose a rare gut disorder, avoiding more invasive procedures.

What could go wrong

This is a very small, early study (20 people) looking only at two genes. It may not find a clear link, and results may not apply to everyone with the condition.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PSEUDO OBSTRUCTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

intestinal pseudo-obstruction

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Ospedale Maggiore Policlinico di Milano

    Milan, 20122, Italy